Skip to main content
Novo Nordisk A/S (NVO)
NYSE: NVO · Real-Time Price · USD
37.45
-0.17 (-0.45%)
At close: Feb 27, 2026, 4:00 PM EST
37.49
+0.04 (0.10%)
After-hours: Feb 27, 2026, 7:59 PM EST

Novo Nordisk Revenue by Segment
Period Ending Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019
Diabetes
33.80B 33.61B 33.39B 32.59B 31.24B 30.40B 28.77B 27.36B
Diabetes Growth
8.19% 10.57% 16.05% 19.11% 22.93% 24.59% 23.92% 24.31%
Obesity
12.82B 12.46B 11.44B 10.27B 8.67B 7.64B 7.07B 6.57B
Obesity Growth
47.92% 63.15% 61.82% 56.48% 53.16% 73.14% 110.41% 146.87%
Rare Disease
3.15B 3.13B 2.98B 2.94B 2.76B 2.65B 2.68B 2.71B
Rare Disease Growth
14.05% 17.73% 11.21% 8.60% 0.34% -9.75% -14.09% -16.45%

Operating Income by Segment
Period Ending Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019
Diabetes and Obesity Care
20.73B 22.19B 21.25B 20.14B 18.56B 17.50B 16.82B 15.71B
Diabetes and Obesity Care Growth
11.67% 26.80% 26.31% 28.20% 29.95% 35.29% 41.90% 47.82%
Rare Disease
191.62M 331.83M 84.53M 97.78M 104.25M 79.49M 431.35M 465.41M
Rare Disease Growth
83.81% 317.46% -80.40% -78.99% -71.50% -87.86% -50.18% -60.20%

Revenue by Geography
Period Ending Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018
North America
28.99B 29.22B 28.89B 28.10B 26.09B 24.90B 23.12B 21.55B
North America Growth
11.10% 17.33% 24.96% 30.41% 37.09% 44.35% 46.01% 49.97%
International
20.79B 19.98B 18.92B 17.70B 16.58B 15.79B 15.40B 15.08B
International Growth
25.36% 26.54% 22.84% 17.36% 12.08% 8.89% 11.10% 11.40%
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.